Published in Urology on May 01, 1985
Primary non-Hodgkin's lymphoma of the bladder with bone marrow involvement. Korean J Intern Med (2003) 0.88
Primary lymphomas of the prostate: two case reports and a review of the literature. Contemp Oncol (Pozn) (2012) 0.75
[Primary lymphoma of the bladder: a case report]. Pan Afr Med J (2014) 0.75
Systemic non-Hodgkin's lymphoma initially presenting as a bladder mass. Urol Ann (2017) 0.75
Tissue-shrinkage correction factor in the calculation of prostate cancer volume. Am J Surg Pathol (1996) 2.06
The human minisatellite consensus at breakpoints of oncogene translocations. Nucleic Acids Res (1990) 1.84
The effect of hospital volume on mortality and resource use after radical prostatectomy. J Urol (2000) 1.60
Giant cyst of the seminal vesicle with renal agenesis. AJR Am J Roentgenol (1987) 1.43
Primary extranodal lymphoma: response to treatment and factors influencing prognosis. Cancer (1978) 1.40
Electrical property sensing biopsy needle for prostate cancer detection. Prostate (2013) 1.39
BCL2 oncogene translocation is mediated by a chi-like consensus. J Exp Med (1992) 1.34
Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: predictive accuracy in needle biopsies. J Urol (1995) 1.33
In vivo description of dendritic cells in human renal cell carcinoma. J Urol (1999) 1.23
Double myeloma. Production of both IgG type lambda and IgA type lambda myeloma proteins by a single plasma cell line. Am J Med (1973) 1.22
S-100 protein positivity in breast carcinomas: a potential pitfall in diagnostic immunohistochemistry. Hum Pathol (1987) 1.22
Metastatic renal cell carcinoma presenting as a skin nodule: case report and review of the literature. J Urol (1994) 1.21
B lymphocyte subpopulations in chronic lymphocytic leukemia. Blood (1976) 1.06
Similarities of the light chains and the variable regions of the heavy chains of the IgG2 lambda and IgA1 lambda myeloma proteins from a single patient. J Immunol (1974) 1.04
Bleomycin pulmonary toxicity. Chest (1973) 1.03
Human parathyroid hormone-related protein in ovarian small cell carcinoma. An immunohistochemical study. Cancer (1994) 0.98
Immunoblastic lymphadenopathy. A mixed proliferation of T and B lymphocytes. Am J Clin Pathol (1977) 0.98
The Non-Hodgkin Lymphoma Pathologic Classification Project. Long-term follow-up of 1153 patients with non-Hodgkin lymphomas. Ann Intern Med (1988) 0.93
Phase I evaluation of recombinant interleukin-2 in patients with advanced malignant disease. J Clin Oncol (1986) 0.93
Vulvar metastases secondary to transitional cell carcinoma of the bladder. A case report. J Reprod Med (1999) 0.93
Familial medullary thyroid carcinoma and C cell hyperplasia. Clin Endocrinol Metab (1981) 0.92
The effect of intravesical thio-tepa on normal and tumor urothelium. J Urol (1978) 0.92
Surface marker and histopathologic correlation with long-term survival in advanced large-cell non-Hodgkin's lymphoma. Cancer (1981) 0.92
Pathways of human B lymphocyte differentiation: a clonal transition between IgM and IgG synthesis in leukemic B lymphocytes. J Immunol (1977) 0.90
Nodal involvement as a prognostic indicator in patients with prostatic carcinoma. J Urol (1980) 0.90
Adrenal insufficiency from bilateral adrenal hemorrhage after total knee replacement surgery. Urology (1997) 0.90
Expression of Fas(APO-1/CD95) in tumor-infiltrating and peripheral blood lymphocytes in patients with renal cell carcinoma. Cancer Res (1998) 0.89
Fatal genitourinary mucormycosis in a patient with undiagnosed diabetes. Clin Infect Dis (1995) 0.89
Use of polyestradiol phosphate and anti-17 beta estradiol antibodies for the localization of estrogen receptors in target tissues: a critique. Cancer (1980) 0.89
Trends in the use of radical prostatectomy for treatment of prostate cancer. Eff Clin Pract (1999) 0.88
Biopsy of apparently normal urothelium in patients with bladder carcinoma. J Urol (1978) 0.87
Prostate-specific antigen. Superior serum marker for prostatic carcinoma. Ir J Med Sci (1987) 0.86
Nodular non-Hodgkin's lymphoma (NHL): factors influencing prognosis and indications for aggressive treatment. Cancer (1979) 0.86
Partial characterization of the shift from IgG to IgA synthesis in the clonal differentiation of human leukemic bone marrow-derived lymphocytes. J Exp Med (1975) 0.86
Treatment of advanced malignant lymphomas with bleomycin. Blood (1972) 0.85
Computed tomographic findings in renal angiomyolipoma: an histologic correlation. Urology (1984) 0.85
Hodgkin's disease presenting as "idiopathic" thrombocytopenic purpura. Cancer (1972) 0.84
Respiratory distress following cesarean section: cryptic presentation of bladder injury. Urology (1994) 0.84
Acquired immunodeficiency syndrome with progressive multifocal leukoencephalopathy and monoclonal B-cell proliferation. Ann Intern Med (1984) 0.84
Multiple myeloma and chronic lymphocytic leukemia in a single individual. Arch Intern Med (1977) 0.83
T-cell receptor zeta-chain expression on tumor-infiltrating lymphocytes from renal cell carcinoma. Cancer Res (1997) 0.82
The binding of IgM aggregates to neoplastic B lymphocytes. II. Fc dependence and implications for a model of B lymphocyte differentiation. J Immunol (1980) 0.82
Psoas abscess following intravesical bacillus Calmette-Guerin for bladder cancer: a case report. J Urol (1993) 0.82
Multifocal pigmentation of prostatic and bladder urothelium. J Urol (1986) 0.82
Infectious mononucleosis in an adult progressing to fatal immunoblastic lymphoma. Ann Intern Med (1982) 0.81
The binding of IgM to B lymphocytes. I. Studies of the binding of aggregated IgM to normal and leukemic human B lymphocytes. Clin Immunol Immunopathol (1980) 0.81
In vivo growth of human bladder cancer cell lines. Invest Urol (1978) 0.81
Staging of prostate cancer with endorectal MR imaging: lessons from a learning curve. Radiographics (1995) 0.80
Theoretical and experimental analysis of air cooling for intracavitary microwave hyperthermia applicators. IEEE Trans Biomed Eng (1994) 0.80
Surgical treatment of verrucous carcinoma of the bladder unassociated with bilharzial cystitis: case report and literature review. J Urol (1995) 0.80
The place of 57Co-bleomycin scanning in the evaluation of tumors. AJR Am J Roentgenol (1977) 0.80
Vicarious excretion of urographic contrast in a multiple trauma patient. Br J Urol (1987) 0.79
Anti-lymphocyte antibody Leu-7 (HNK-1) recognizes a constituent of neuroendocrine granule matrix. J Histochem Cytochem (1986) 0.79
Prognosis of clinically undiagnosed prostatic carcinoma and the influence of endocrine therapy. J Urol (1977) 0.79
Phase I pilot trial of the bispecific antibody MDXH210 (anti-Fc gamma RI X anti-HER-2/neu) in patients whose prostate cancer overexpresses HER-2/neu. J Immunother (2001) 0.79
Lectins as a probe for carbohydrate residues in non-neoplastic urothelium of human urinary bladder. J Urol (1982) 0.78
Clinical and cell surface marker characterization of the early phase of chronic lymphocytic leukemia. Blood (1978) 0.78
Cell surface coat of human and rat bladder urothelium. I. Ruthenium-red studies in non-neoplastic and neoplastic cells. Virchows Arch B Cell Pathol Incl Mol Pathol (1983) 0.78
Retroperitoneal leiomyosarcoma: a rare cause of adrenal pseudotumor on CT and MRI. Urol Radiol (1988) 0.78
Immunohistochemical demonstration of chromogranin in endometrial carcinomas with argyrophil cells. Hum Pathol (1986) 0.78
Successful treatment of radiation pericarditis with corticosteroids. Arch Intern Med (1974) 0.78
Nephrogenic adenoma and embryonic kidney tubules share PNA receptor sites. Am J Clin Pathol (1984) 0.78
Malignant granular lymphoproliferation after Epstein-Barr virus infection: partial immunologic reconstitution with interleukin-2. Am J Hematol (1987) 0.77
A coaxial microwave applicator for transurethral hyperthermia of the prostate. Prostate (1993) 0.77
Total thyroidectomy for occult familial medullary carcinoma of the thyroid in children. J Pediatr Surg (1976) 0.77
Long term survivors with leptomeningeal tumor involvement. Int J Radiat Oncol Biol Phys (1983) 0.77
Metastatic endotracheal tumor from ovarian carcinoma. Chest (1980) 0.77
Hemorrhagic myelolipoma of adrenal gland after blunt trauma. Urology (1991) 0.76
Continuous infusion of intrathecal morphine to control acquired immunodeficiency syndrome-associated bladder pain. J Urol (1992) 0.76
Postoperative radiation therapy for muscle-invading bladder carcinoma. J Surg Oncol (1983) 0.76
IgD-Fc receptors on normal and neoplastic human B lymphocytes. Clin Exp Immunol (1982) 0.75
Medullary thyroid carcinoma in female BALB/c mice. A report of 3 cases with ultrastructural, immunohistochemical, and transplantation data. Am J Pathol (1983) 0.75
Multiple myeloma with IgG (lambda) and IgA (lambda) serum M-components: immunohistologic studies. J Lab Clin Med (1971) 0.75
Atypical lymphohistiocytic infiltrate (pseudolymphoma) of the oral cavity. Oral Surg Oral Med Oral Pathol (1988) 0.75
Ileal conduit undiversion: experience with tunneled vesical implantation of tapered conduit. J Urol (1980) 0.75
Clinical usefulness of 67gallium scanning in the malignant lymphomas. Am J Med (1976) 0.75
Prognostic factors for patients with diffuse large cell or immunoblastic non-Hodgkin's lymphomas: experience of the non-Hodgkin's Lymphoma Pathologic Classification Project. Med Pediatr Oncol (1990) 0.75
An in vivo model system of human bladder cancer. Surg Forum (1976) 0.75
A clinical trial of adriamycin in the malignant lymphomas. Cancer (1974) 0.75
Segmental calculus disease: potential of parital nephrectomy. Urology (1981) 0.75
Effect of microwave oven heating times on androgen receptor antigen retrieval from paraffin-embedded prostatic adenocarcinoma. Anticancer Res (1996) 0.75
Lymphocyte subsets in primary biliary cirrhosis. Ann Intern Med (1984) 0.75
Letter: Autoimmune thrombocytopenic purpura in Hodgkin's disease. N Engl J Med (1974) 0.75
Myeloproliferative disorder with lytic osseous lesions and chromosomal anomalies. Am J Clin Pathol (1974) 0.75
Surface marker identification of small cleaved follicular center cell lymphomas with a highly favorable prognosis. Cancer Res (1982) 0.75
The relative roles of gallium-67-citrate scanning and lymphangiography in the current management of malignant lymphoma. Cancer (1977) 0.75
The binding of IgM to B lymphocytes: a comparison of the binding characteristics of IgM aggregates and EAB (IgM) complexes to normal and leukemic B lymphocytes. Proc Soc Exp Biol Med (1983) 0.75
Surface markers in non-Hodgkin's lymphomas. Hosp Pract (Off Ed) (1983) 0.75
The B cell IgM Fc receptor: further evidence for the B cell origin of "null" chronic lymphocytic leukemia. Blood (1984) 0.75
Oral urea therapy in sickle-cell anemia. A preliminary report. Ann Intern Med (1972) 0.75
Benign pulmonary nodule and small-cell cancer. Ann Intern Med (1982) 0.75
Myeloma renal disease: evaluation of the role of muramidase (lysozyme). Am J Med Sci (1971) 0.75
Cutaneous delayed hypersensitivity, T cell subsets, and IL-2 secretion in patients with peripheral vascular disease. J Clin Lab Immunol (1985) 0.75
Immunoglobulin phenotype in CLL. Blood (1984) 0.75
Prognosis of diffuse (non-nodular) non-Hodgkin's lymphoma. Cancer Chemother Rep (1975) 0.75
Bleomycin: pulmonary toxicity. Ann Intern Med (1973) 0.75